Further to DrugAlert volume 849, HPS Pharmacies advise that Organon Pharma is continuing to experience a supply interruption of Celestone® Chronodose® Injection Ampoule, as follows:
Celestone® Chronodose® Injection Ampoule
Betamethasone (as acetate and sodium phosphate) 5.7 mg/mL
Normal supplies are expected to return in August 2023. During this period, supplies will be available on a restricted basis to critically ill patients. Specifically, Organon is prioritising supply for antepartum use in the prevention of respiratory distress syndrome in premature infants prior to 32 weeks of gestation. Stock for antepartum use can be ordered by contacting Organon Customer Service at [email protected].
HPS Pharmacies has sourced an internationally registered alternative which may be accessed via the Special Access Scheme (SAS). Please note that this product is subject to a longer lead-time (2-3 weeks) and different pricing as it must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Organon Pharma on 1800 024 874 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates